SGLTR M Tablet

Introduction of SGLTR M Tablet 

SGLTR M Tablet is an oral antidiabetic medicine used for the management of type 2 diabetes mellitus. It is a combination therapy designed to improve blood sugar control by targeting multiple mechanisms involved in glucose regulation.

Description

SGLTR M Tablet combines an SGLT-2 inhibitor and metformin to manage blood sugar effectively. The SGLT-2 inhibitor promotes glucose excretion through urine, while metformin reduces liver glucose production and improves insulin sensitivity. This combination provides better glycemic control for patients whose blood sugar is not adequately managed with a single agent.

Benefits

Lowers and controls blood sugar levels in type 2 diabetes

Supports multiple mechanisms for effective glucose regulation

Helps reduce diabetes-related complications

Can be used as part of a comprehensive diabetes management plan with diet and exercise

How to Use

Take SGLTR M Tablet exactly as prescribed by your healthcare provider

Usually taken once or twice daily, with meals to minimize gastrointestinal discomfort

Swallow the tablet whole with water

Do not crush or chew the tablet

Follow your doctor’s instructions regarding dosage and duration

Side Effects

Some patients may experience:

Common Side Effects

Increased urination

Thirst or dry mouth

Mild gastrointestinal discomfort (nausea, diarrhea)

Less Common Side Effects

Low blood sugar (hypoglycemia, especially if used with other antidiabetic medicines)

Dehydration

Urinary tract or genital infections

Fatigue or dizziness

If side effects persist or worsen, consult your doctor immediately.

Precautions

Not recommended for type 1 diabetes

Use cautiously in patients with kidney or liver problems

Maintain adequate fluid intake during treatment

Inform your doctor about other medications or health conditions

Regular monitoring of blood sugar and kidney function is advised